Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent evidence suggests that there is a link between metabolic diseases and bacterial populations in the gut. The aim of this study was to assess the differences between the composition of the intestinal microbiota in humans with type 2 diabetes and non-diabetic persons as control. METHODS AND FINDINGS: The study included 36 male adults with a broad range of age and body-mass indices (BMIs), among which 18 subjects were diagnosed with diabetes type 2. The fecal bacterial composition was investigated by real-time quantitative PCR (qPCR) and in a subgroup of subjects (N = 20) by tag-encoded amplicon pyrosequencing of the V4 region of the 16S rRNA gene. The proportions of phylum Firmicutes and class Clostridia were significantly reduced in the diabetic group compared to the control group (P = 0.03). Furthermore, the ratios of Bacteroidetes to Firmicutes as well as the ratios of Bacteroides-Prevotella group to C. coccoides-E. rectale group correlated positively and significantly with plasma glucose concentration (P = 0.04) but not with BMIs. Similarly, class Betaproteobacteria was highly enriched in diabetic compared to non-diabetic persons (P = 0.02) and positively correlated with plasma glucose (P = 0.04). CONCLUSIONS: The results of this study indicate that type 2 diabetes in humans is associated with compositional changes in intestinal microbiota. The level of glucose tolerance should be considered when linking microbiota with metabolic diseases such as obesity and developing strategies to control metabolic diseases by modifying the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compelling evidence have shown that the composition of the gut microbiota is altered in animal models of obesity and subjects with prediabetes or type 2 diabetes compared with controls (182–186).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Chronic autoimmune inflammatory diseases, including celiac disease,17 type 2 diabetes18 and obesity19 are associated with intestinal dysbiosis.”
From Probiotics and the gut microbiota in intestinal health and disease (2010) · cites this paper as [18]
In the citing paper
“Conversely, heterocyclic amines and glycan derived from red meat may promote inflammation in gut health due to higher concentration of Bacteroides and Fusobacterium and lower levels of Lactobacillus and Roseburia, which are also linked with lower anti-inflammatory responses and increased incidence of type 2 diabetes [191,192,193].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
[RETRACTION]Translational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M., Carvalho, B. M., Carvalho-Filho, M. A., & Saad, M. J. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200004 · Cited by 44
RetractedTranslational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M. L., Carvalho, B. M., Filho, C., & Saad, M. J. A. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000900014 · Cited by 17
RetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“The differences in microbial composition were explained by an increased capacity of the obesity-associated microbiome to harvest energy from the diet [13].”
BackgroundA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 2×
“For example, levels of Bifidobacterium significantly and positively correlated with improved glucose-tolerance and low-grade inflammation in prebiotic treated-mice [1,6].”
BackgroundMicrobiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457
Cited by
Items 201–300 of 1,020
Davey, K. J., O’Mahony, S. M., Schellekens, H., O’Sullivan, O., Bienenstock, J., Cotter, P. D., Dinan, T. G., & Cryan, J. F. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2555-2 · Cited by 275
Gastrointestinal Anatomy and Physiology
Denbow, D. M. (2015) · Sturkie's Avian Physiology · doi:10.1016/b978-0-12-407160-5.00014-2 · Cited by 269
Beneficial modulation of the gut microbiota
Walsh, C. J., Guinane, C. M., O'Toole, P. W., & Cotter, P. D. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.035 · Cited by 274
“[46–48], although, as with many obesity-related associations, it is not clear whether these changes are a cause or simply a conse-”
BackgroundThe Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Rahman, M. M., Islam, F., -Or-Rashid, M. H., Mamun, A. A., Rahaman, M. S., Islam, M. M., Meem, A. F. K., Sutradhar, P. R., Mitra, S., Mimi, A. A., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.903570 · Cited by 253
Hooda, S., Boler, B. M. V., Serao, M. C. R., Brulc, J. M., Staeger, M. A., Boileau, T. W., Dowd, S. E., Fahey, G. C., & Swanson, K. S. (2012) · The Journal of Nutrition · doi:10.3945/jn.112.158766 · Cited by 272
“The diversity and composition of the gut microbiota have been reported to be influenced by age (7), genetics (8), and, most importantly, diet (9).”
BackgroundGut microorganisms as promising targets for the management of type 2 diabetes
Delzenne, N. M., Cani, P. D., Everard, A., Neyrinck, A. M., & Bindels, L. B. (2015) · Diabetologia · doi:10.1007/s00125-015-3712-7 · Cited by 262
Gut microbiota and diabetes: from pathogenesis to therapeutic perspective
Burcelin, R., Serino, M., Chabo, C., Blasco-Baque, V., & Amar, J. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0333-6 · Cited by 257
“Recently, intestinal microbiota ecology has been shown to shape metabolic diseases itself such as obesity [32] and diabetes [33].”
BackgroundMosele, J., Macià, A., & Motilva, M.-J. (2015) · Molecules · doi:10.3390/molecules200917429 · Cited by 257
The gut microbiota: A treasure for human health
Li, D., Wang, P., Wang, P., Hu, X., & Chen, F. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.08.003 · Cited by 261
“Recently, increasing evidence indicates that altered gutmicrobiota is associatedwith the development of T2D (Larsen et al., 2010; Qin et al., 2012; Karlsson et al., 2013).”
BackgroundResultRole of the Gut Microbiome in Obesity and Diabetes Mellitus
Barlow, G. M., Yu, A., & Mathur, R. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615609896 · Cited by 262
Microbial ecology and host-microbiota interactions during early life stages
Collado, M. C., Cernada, M., Baüerl, C., Vento, M., & Pérez-Martínez, G. (2012) · Gut Microbes · doi:10.4161/gmic.21215 · Cited by 256
Programming of Host Metabolism by the Gut Microbiota
Bäckhed, F. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000328042 · Cited by 255
“Only a few studies aimed to investigate if the gut microbiota is altered in patients with type 2 diabetes. Larsen et al. [”
BackgroundUnhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases
Spielman, L. J., Gibson, D. L., & Klegeris, A. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.005 · Cited by 266
“present in the gut when compared to healthy controls (Larsen et al., 2010).”
Diversified Microbiota of Meconium Is Affected by Maternal Diabetes Status
Hu, J., Nomura, Y., Bashir, A., Fernandez-Hernandez, H., Itzkowitz, S., Pei, Z., Stone, J., Loudon, H., & Peter, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078257 · Cited by 257
Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?
Brahe, L. K., Astrup, A., & Larsen, L. H. (2013) · Obesity Reviews · doi:10.1111/obr.12068 · Cited by 264
“However, some studies have not found an association between obesity and the Bacteroidetes/Firmicutes ratio in the human faecal microbiome using fluorescent in situ hybridization (13), real-time polymerase chain reaction (PCR) analysis (14,15) or combined results from Sanger sequencing and pyrosequencing (16), while ot…”
BackgroundProbiotics, Prebiotics, and Synbiotics: Gut and Beyond
Vyas, U., & Ranganathan, N. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/872716 · Cited by 256
“One study in adult population with type 2 diabetes [42] has shown that their gut microbiota differs from that of non-diabetic adults, and that health may potentially improve when the gut microflora is modified by the administration of probiotics and prebiotics.”
BackgroundGut microbiota and metabolic syndrome
Wang, P.-X., Deng, X.-R., Zhang, C.-H., & Yuan, H.-J. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000696 · Cited by 246
“Several studies have found a significant association between hyperglycemia and dysbiosis of the gut microbiota, but the results were inconsistent, highlighting the need for further studies.([14-16])”
ResultLópez, P., de Paz, B., Rodríguez-Carrio, J., Hevia, A., Sánchez, B., Margolles, A., & Suárez, A. (2016) · Scientific Reports · doi:10.1038/srep24072 · Cited by 262
Gut microbiome in chronic kidney disease: challenges and opportunities
Nallu, A., Sharma, S., Ramezani, A., Muralidharan, J., & Raj, D. (2017) · Translational Research · doi:10.1016/j.trsl.2016.04.007 · Cited by 255
Microbial modulation of insulin sensitivity
Khan, M. T., Nieuwdorp, M., & Bäckhed, F. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.006 · Cited by 260
Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet
Candela, M., Biagi, E., Soverini, M., Consolandi, C., Quercia, S., Severgnini, M., Peano, C., Turroni, S., Rampelli, S., Pozzilli, P., et al. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516001045 · Cited by 260
“Strengthening these findings, analogous T2D-associated GM structural dysbioses have already been identified in previous studies((3,6,7,47)).”
ResultThe role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity
Tai, N., Wong, F. S., & Wen, L. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-015-9309-0 · Cited by 252
“The authors found the compositional changes in the gut microbiota were associated with T2D at both phylum and class levels [97].”
BackgroundChahwan, B., Kwan, S., Isik, A., van Hemert, S., Burke, C., & Roberts, L. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.097 · Cited by 256
“, 2009), Type-2 diabetes (Larsen et al., 2010), celiac disease (De Palma et al.”
BackgroundKrych, L., Hansen, C. H. F., Hansen, A. K., van den Berg, F. W. J., & Nielsen, D. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062578 · Cited by 249
“PCR amplification of the 16S rRNA gene plus purification and pyrosequencing of amplified PCR products were carried out as previously described [5].”
Self-citationDiversity and Abundance of Single-Stranded DNA Viruses in Human Feces
Kim, M.-S., Park, E.-J., Roh, S. W., & Bae, J.-W. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.06331-11 · Cited by 247
“For this reason, changes in their relative abundances are closely related to the prevalence of obesity, gut inflammation, and autoimmune disease (17, 25, 57).”
BackgroundXiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota
Wei, X., Tao, J., Xiao, S., Jiang, S., Shang, E., Zhu, Z., Qian, D., & Duan, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22094-2 · Cited by 256
Resveratrol, Metabolic Syndrome, and Gut Microbiota
Chaplin, A., Carpéné, C., & Mercader, J. (2018) · Nutrients · doi:10.3390/nu10111651 · Cited by 242
Gut microbiota in patients with obesity and metabolic disorders — a systematic review
XU, Z., JIANG, W., HUANG, W., LIN, Y., CHAN, F. K. L., & NG, S. C. (2022) · Genes & Nutrition · doi:10.1186/s12263-021-00703-6 · Cited by 234
Simon, M.-C., Strassburger, K., Nowotny, B., Kolb, H., Nowotny, P., Burkart, V., Zivehe, F., Hwang, J.-H., Stehle, P., Pacini, G., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2690 · Cited by 253
Lifestyle Medicine: A Brief Review of Its Dramatic Impact on Health and Survival
Bodai, B. I., Nakata, T. E., Wong, W. T., Clark, D. R., Lawenda, S., Tsou, C., Liu, R., Shiue, L., Cooper, N., Rehbein, M., et al. (2018) · The Permanente Journal · doi:10.7812/tpp/17-025 · Cited by 253
Disbiome database: linking the microbiome to disease
Janssens, Y., Nielandt, J., Bronselaer, A., Debunne, N., Verbeke, F., Wynendaele, E., Van Immerseel, F., Vandewynckel, Y.-P., De Tré, G., & De Spiegeleer, B. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1197-5 · Cited by 250
“diabetes [18], Crohn’s disease [19], ulcerative colitis [20], autism [21], bacterial vaginosis [22] and psoriasis [23].”
BackgroundPutignani, L., Del Chierico, F., Petrucca, A., Vernocchi, P., & Dallapiccola, B. (2014) · Pediatric Research · doi:10.1038/pr.2014.49 · Cited by 245
“Indeed dysbiosis is the prelude to a wide range of diseases, such as obesity (11,33), type 2 diabetes (33,34), liver steatosis (18,35), behavior abnormalities (36,37), atopy and allergy (38,39), metabolic disorders (40), inflammatory disorders (14,41), inflammatory bowel diseases (42), including enterocolitis, necroti…”
BackgroundAn analysis of human microbe–disease associations
Ma, W., Zhang, L., Zeng, P., Huang, C., Li, J., Geng, B., Yang, J., Kong, W., Zhou, X., & Cui, Q. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbw005 · Cited by 244
Everard, A., Geurts, L., Caesar, R., Van Hul, M., Matamoros, S., Duparc, T., Denis, R. G. P., Cochez, P., Pierard, F., Castel, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6648 · Cited by 237
“A large body of evidence suggests that the gut microbiota is altered in obesity and type 2 diabetes 1–4 .”
MECHANISMS IN ENDOCRINOLOGY: Gut microbiota in patients with type 2 diabetes mellitus
Allin, K. H., Nielsen, T., & Pedersen, O. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0874 · Cited by 233
Zhu, L., Zhang, D., Zhu, H., Zhu, J., Weng, S., Dong, L., Liu, T., Hu, Y., & Shen, X. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.11.023 · Cited by 243
Extensive Strain-Level Copy-Number Variation across Human Gut Microbiome Species
Greenblum, S., Carr, R., & Borenstein, E. (2015) · Cell · doi:10.1016/j.cell.2014.12.038 · Cited by 244
“…studies aiming to characterize the contribution of the microbiome to human health have already demonstrated marked shifts in the relative abundance of various species, genera, or phyla in various disease states (Frank et al., 2007; Hoffman et al., 2014; Larsen et al., 2010; Turnbaugh et al., 2009).”
Influence of Diet and Nutrition on Prostate Cancer
Matsushita, M., Fujita, K., & Nonomura, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041447 · Cited by 223
“Interestingly, studies suggest that gut microbiota is involved not only in intestinal diseases but also in diseases in other organs, with several laboratory and human studies suggesting its involvement in Alzheimer’s disease [137,138], rheumatoid arthritis [139,140], and diabetes [141,142].”
ResultNon-alcoholic fatty liver and the gut microbiota
Bashiardes, S., Shapiro, H., Rozin, S., Shibolet, O., & Elinav, E. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.003 · Cited by 241
Hasain, Z., Mokhtar, N. M., Kamaruddin, N. A., Mohamed Ismail, N. A., Razalli, N. H., Gnanou, J. V., & Raja Ali, R. A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00188 · Cited by 225
Duttaroy, A. K. (2021) · Nutrients · doi:10.3390/nu13010144 · Cited by 223
“↑Lactobacillus [50] ↓Roseburiam [22] ↑Firmicutes / Bacteroides ratio [51] ↑Firmicutes [52] [53-57] Bacteroides [54]”
Impact of gut microbiota on diabetes mellitus
Blandino, G., Inturri, R., Lazzara, F., Di Rosa, M., & Malaguarnera, L. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.04.004 · Cited by 231
“[38] Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS,”
BackgroundAxling, U., Olsson, C., Xu, J., Fernandez, C., Larsson, S., Ström, K., Ahrné, S., Holm, C., Molin, G., & Berger, K. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-105 · Cited by 227
“Also, the pathogenesis of obesity and type 2 diabetes has been associated with a dysfunctional gut microbiota [3,4].”
The critical role of gut microbiota in obesity
Cheng, Z., Zhang, L., Yang, L., & Chu, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1025706 · Cited by 233
Tran, T. T. T., Corsini, S., Kellingray, L., Hegarty, C., Le Gall, G., Narbad, A., Müller, M., Tejera, N., O'Toole, P. W., Minihane, A.-M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900071r · Cited by 233
The gut microbiota of Colombians differs from that of Americans, Europeans and Asians
Escobar, J. S., Klotz, B., Valdes, B. E., & Agudelo, G. M. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0311-6 · Cited by 227
“However, dysbiosis is associated with clinical conditions, such as obesity [8], diabetes [9,10] and cancer [11].”
BackgroundYoo, S., Kim, Y., Park, D., Jung, U., Jeon, S., Ahn, Y., Huh, C., McGregor, R., & Choi, M. S. (2013) · Obesity · doi:10.1002/oby.20428 · Cited by 230
“While we are far from understanding the function of the bacterial species residing in the mammalian gut, studies in recent years have established that the gut microbiota composition is altered in obesity (2-3) and related metabolic disorders (4-5).”
BackgroundSon, J. S., Zheng, L. J., Rowehl, L. M., Tian, X., Zhang, Y., Zhu, W., Litcher-Kelly, L., Gadow, K. D., Gathungu, G., Robertson, C. E., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137725 · Cited by 229
“QPCR assays were performed using established primers for total bacteria (forward, 5’- GTG STG CAY GGY TGT CGT CA-3’ and reverse 5’- ACG TCR TCCMCA CCT TCC TC-3’) [38], Sutterella subgroup (forward, 5’-CGC GAA AAA CCT TAC CTA GCC-3’ and reverse 5’GAC GTG TGA GGC CCT AGC C-3’) [10], Bacteroidetes subgroup (forward 5'-AA…”
MethodAltered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
Sircana, A., Framarin, L., Leone, N., Berrutti, M., Castellino, F., Parente, R., De Michieli, F., Paschetta, E., & Musso, G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1057-6 · Cited by 223
Yan, F., Li, N., Shi, J., Li, H., Yue, Y., Jiao, W., Wang, N., Song, Y., Huo, G., & Li, B. (2019) · Food & Function · doi:10.1039/c9fo01062a · Cited by 222
Firouzi, S., Majid, H. A., Ismail, A., Kamaruddin, N. A., & Barakatun-Nisak, M.-Y. (2017) · European Journal of Nutrition · doi:10.1007/s00394-016-1199-8 · Cited by 216
GPR43 Potentiates β-Cell Function in Obesity
McNelis, J. C., Lee, Y. S., Mayoral, R., van der Kant, R., Johnson, A. M. F., Wollam, J., & Olefsky, J. M. (2015) · Diabetes · doi:10.2337/db14-1938 · Cited by 224
The Human Microbiome: From Symbiosis to Pathogenesis
Eloe-Fadrosh, E. A., & Rasko, D. A. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-010312-133513 · Cited by 210
Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications
Zhang, L., Chu, J., Hao, W., Zhang, J., Li, H., Yang, C., Yang, J., Chen, X., & Wang, H. (2021) · Mediators of Inflammation · doi:10.1155/2021/5110276 · Cited by 201
“The fi rst study on gut microbiota of T2DM was reported in 2010 [6].”
Plasma Lipopolysaccharide Is Closely Associated With Glycemic Control and Abdominal Obesity
Trøseid, M., Nestvold, T. K., Rudi, K., Thoresen, H., Nielsen, E. W., & Lappegård, K. T. (2013) · Diabetes Care · doi:10.2337/dc13-0451 · Cited by 217
“An altered gut microbiota has been linked to several chronic disease states, including obesity (6) and type 2 diabetes (7).”
BackgroundThe intestinal microbiota and its role in human health and disease
Kataoka, K. (2016) · The Journal of Medical Investigation · doi:10.2152/jmi.63.27 · Cited by 211
Aging, Frailty, and the Microbiome—How Dysbiosis Influences Human Aging and Disease
Haran, J. P., & McCormick, B. A. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.060 · Cited by 216
Ruan, Y., Sun, J., He, J., Chen, F., Chen, R., & Chen, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132121 · Cited by 210
“Interestingly, research shows that gut microbiota are involved in diabetes and metabolic disorders, revealing that diabetic patients have altered gut microbiota compared to non-diabetic counterparts [10].”
Changes in gut microbiota due to supplemented fatty acids in diet-induced obese mice
Mujico, J. R., Baccan, G. C., Gheorghe, A., Díaz, L. E., & Marcos, A. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512005612 · Cited by 218
Functional analysis of colonic bacterial metabolism: relevant to health?
Hamer, H. M., De Preter, V., Windey, K., & Verbeke, K. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00048.2011 · Cited by 216
Farnelid, H., Andersson, A. F., Bertilsson, S., Al-Soud, W. A., Hansen, L. H., Sørensen, S., Steward, G. F., Hagström, Å., & Riemann, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019223 · Cited by 209
“The amplified fragments were quantified using a Qubit fluorometer (Invitrogen) and quantitative PCR (Mx3000 thermocycler; Stratagene) as previously described [15], mixed in equal amounts, and sequenced in a two-region 454 run on a 70675 GS PicoTiterPlate using a GS FLX pyrosequencing system according to manufacturer i…”
MethodSelf-citationWinek, K., Engel, O., Koduah, P., Heimesaat, M. M., Fischer, A., Bereswill, S., Dames, C., Kershaw, O., Gruber, A. D., Curato, C., et al. (2016) · Stroke · doi:10.1161/strokeaha.115.011800 · Cited by 212
Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans
Sanapareddy, N., Legge, R. M., Jovov, B., McCoy, A., Burcal, L., Araujo-Perez, F., Randall, T. A., Galanko, J., Benson, A., Sandler, R. S., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.43 · Cited by 221
“, 2009) although this has been controversial (Larsen et al., 2010).”
BackgroundZhu, L., Sha, L., Li, K., Wang, Z., Wang, T., Li, Y., Liu, P., Dong, X., Dong, Y., Zhang, X., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-019-1167-4 · Cited by 214
Xu, J., Liang, R., Zhang, W., Tian, K., Li, J., Chen, X., Yu, T., & Chen, Q. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.12986 · Cited by 209
“Gut dysbiosis is induced by the DM state.(13) Conversely, the imbalance of gut microbiota plays a critical role in the DM development.”
BackgroundWang, H., Lu, Y., Yan, Y., Tian, S., Zheng, D., Leng, D., Wang, C., Jiao, J., Wang, Z., & Bai, Y. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00455 · Cited by 210
Martínez, I., Perdicaro, D. J., Brown, A. W., Hammons, S., Carden, T. J., Carr, T. P., Eskridge, K. M., & Walter, J. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.03046-12 · Cited by 215
“Accordingly, the gut microbiota is increasingly being accepted as an important 55 factor that contributes to pathological conditions associated with obesity (9), and in humans, 56 metabolic pathologies are often associated with alterations in the gut microbiota (which is 57 referred to as dysbiosis) (23, 24, 39, 50).”
Is bile acid a determinant of the gut microbiota on a high-fat diet?
Yokota, A., Fukiya, S., Islam, K. B. M. S., Ooka, T., Ogura, Y., Hayashi, T., Hagio, M., & Ishizuka, S. (2012) · Gut Microbes · doi:10.4161/gmic.21216 · Cited by 207
Tachon, S., Zhou, J., Keenan, M., Martin, R., & Marco, M. L. (2013) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2012.01475.x · Cited by 205
“Perturbations of the intestinal microbiota have been associated with immune, metabolic, and neurological diseases (Ley et al., 2006; Finegold et al., 2010; Hong et al., 2010; Larsen et al., 2010).”
BackgroundIntegrative Personal Omics Profiles during Periods of Weight Gain and Loss
Piening, B. D., Zhou, W., Contrepois, K., Röst, H., Gu Urban, G. J., Mishra, T., Hanson, B. M., Bautista, E. J., Leopold, S., Yeh, C. Y., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2017.12.013 · Cited by 212
“Interestingly, a prior study showed that Firmicutes abundance was reduced in patients with T2DM relative to healthy controls (Larsen et al., 2010), so it is possible that, upon progression from a prediabetic state to outright diabetes, a remodeling of the microbiome occurs, again emphasizing the need for detailed long…”
BackgroundChou, H.-H., Chien, W.-H., Wu, L.-L., Cheng, C.-H., Chung, C.-H., Horng, J.-H., Ni, Y.-H., Tseng, H.-T., Wu, D., Lu, X., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424775112 · Cited by 211
“Primer Eub2 targeting 16S rRNA was used to measure the amount of eubacteria in the stool (34).”
MethodGut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity
Lazar, V., Ditu, L.-M., Pircalabioru, G. G., Picu, A., Petcu, L., Cucu, N., & Chifiriuc, M. C. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00021 · Cited by 210
“A Chinese study reported an increase of Escherichia coli in T2DM patients while a Danish study reported elevated Proteobacteria in T2DM (84).”
BackgroundWacklin, P., Kaukinen, K., Tuovinen, E., Collin, P., Lindfors, K., Partanen, J., Mäki, M., & Mättö, J. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828029a9 · Cited by 207
Li, K., Zhang, L., Xue, J., Yang, X., Dong, X., Sha, L., Lei, H., Zhang, X., Zhu, L., Wang, Z., et al. (2019) · Food & Function · doi:10.1039/c8fo02265h · Cited by 206
Tanase, D. M., Gosav, E. M., Neculae, E., Costea, C. F., Ciocoiu, M., Hurjui, L. L., Tarniceriu, C. C., Maranduca, M. A., Lacatusu, C. M., Floria, M., et al. (2020) · Nutrients · doi:10.3390/nu12123719 · Cited by 207
A. Parnell, J., & A. Reimer, R. (2012) · Gut Microbes · doi:10.4161/gmic.19246 · Cited by 203
“Furthermore, the ratio of Bacteroidetes to Firmicutes is positively correlated with plasma glucose concentrations.(53) In support of gut microbial dysbiosis in type 2 diabetes development, we found Bacteroides and total bacteria were negatively correlated with fasting insulin and insulin incremental area under the cur…”
BackgroundNie, Q., Hu, J., Gao, H., Fan, L., Chen, H., & Nie, S. (2019) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2017.12.026 · Cited by 208
Nie, Q., Chen, H., Hu, J., Fan, S., & Nie, S. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1536646 · Cited by 204
“The increased ratio of Firmicutes/Bacteroidetes was positively correlated with weight gain and negatively correlated with glucose concentration (Larsen et al. 2010).”
BackgroundLi, X., Brejnrod, A. D., Ernst, M., Rykær, M., Herschend, J., Olsen, N. M. C., Dorrestein, P. C., Rensing, C., & Sørensen, S. J. (2019) · Environment International · doi:10.1016/j.envint.2019.02.048 · Cited by 203
Self-citationInteractive relationships between intestinal flora and bile acids
Guo, X., Okpara, E. S., Hu, W., Yan, C., Wang, Y., Liang, Q., Chiang, J. Y. L., & Han, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158343 · Cited by 206
Hwang, I., Park, Y. J., Kim, Y., Kim, Y. N., Ka, S., Lee, H. Y., Seong, J. K., Seok, Y., & Kim, J. B. (2015) · The FASEB Journal · doi:10.1096/fj.14-265983 · Cited by 206
“In the present study, there was an increase in the relative abundance of Proteobacteria in conjunction with the reduction of Firmicutes and Bacteroidetes in the Ab-NH group.”
BackgroundInfluentialThe gut microbiome is altered in a letrozole-induced mouse model of polycystic ovary syndrome
Kelley, S. T., Skarra, D. V., Rivera, A. J., & Thackray, V. G. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146509 · Cited by 205
Su, D., Nie, Y., Zhu, A., Chen, Z., Wu, P., Zhang, L., Luo, M., Sun, Q., Cai, L., Lai, Y., et al. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00498 · Cited by 197
“Unbalanced gut microbiota (dysbiosis), on the other hand, may lead to alteration of immunity and increased risk of diverse diseases, including type-2 diabetes and obesity (Bäckhed et al., 2004; Ley et al., 2005; Larsen et al., 2010).”
BackgroundYan, H., Lu, J., Wang, Y., Gu, W., Yang, X., & Yu, J. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.01.007 · Cited by 203
Liang, D., Leung, R. K.-K., Guan, W., & Au, W. W. (2018) · Gut Pathogens · doi:10.1186/s13099-018-0230-4 · Cited by 203
Sex, microbes, and polycystic ovary syndrome
Thackray, V. G. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.11.001 · Cited by 203
Cai, T.-T., Ye, X.-L., Li, R.-R., Chen, H., Wang, Y.-Y., Yong, H.-J., Pan, M.-L., Lu, W., Tang, Y., Miao, H., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01249 · Cited by 202
“The increased abundance of the Alloprevotella in the db/ db+resveratrol has previously been linked to beneficial intestinal health and to aberrant production of metabolic endotoxin (Larsen et al., 2010).”
BackgroundIntestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease
Sabatino, A., Regolisti, G., Cosola, C., Gesualdo, L., & Fiaccadori, E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0841-z · Cited by 200
Kobyliak, N., Falalyeyeva, T., Mykhalchyshyn, G., Kyriienko, D., & Komissarenko, I. (2018) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2018.04.015 · Cited by 196
The developing intestinal microbiome and its relationship to health and disease in the neonate
Torrazza, R. M., & Neu, J. (2011) · Journal of Perinatology · doi:10.1038/jp.2010.172 · Cited by 191
Gut microbiota bridges dietary nutrients and host immunity
Fan, L., Xia, Y., Wang, Y., Han, D., Liu, Y., Li, J., Fu, J., Wang, L., Gan, Z., Liu, B., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2346-1 · Cited by 189
“cutes, one of the most abundant prokaryotic groups in human gut microbiota that is responsible for type 2 diabetes (T2D), obesity, and Alzheimer’s disease (Larsen et al., 2010; Vogt et al., 2017).”
BackgroundBryrup, T., Thomsen, C. W., Kern, T., Allin, K. H., Brandslund, I., Jørgensen, N. R., Vestergaard, H., Hansen, T., Hansen, T. H., Pedersen, O., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4848-7 · Cited by 200
Metabolic inflammation: Connecting obesity and insulin resistance
Dali-Youcef, N., Mecili, M., Ricci, R., & Andrès, E. (2013) · Annals of Medicine · doi:10.3109/07853890.2012.705015 · Cited by 190
A broken promise: microbiome differential abundance methods do not control the false discovery rate
Hawinkel, S., Mattiello, F., Bijnens, L., & Thas, O. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbx104 · Cited by 199
George, F., Daniel, C., Thomas, M., Singer, E., Guilbaud, A., Tessier, F. J., Revol-Junelles, A.-M., Borges, F., & Foligné, B. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02899 · Cited by 198
Implication of the gut microbiome composition of type 2 diabetic patients from northern China
Li, Q., Chang, Y., Zhang, K., Chen, H., Tao, S., & Zhang, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-62224-3 · Cited by 192
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors
Montalban-Arques, A., Katkeviciute, E., Busenhart, P., Bircher, A., Wirbel, J., Zeller, G., Morsy, Y., Borsig, L., Glaus Garzon, J. F., Müller, A., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.08.001 · Cited by 197
Lee, C. K., Herbold, C. W., Polson, S. W., Wommack, K. E., Williamson, S. J., McDonald, I. R., & Cary, S. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044224 · Cited by 190
“High-throughput pyrosequencing of PCR amplicons has emerged as a valuable technique in microbial ecology and revealed, in unprecedented detail, the microbial diversities found in various marine and terrestrial environments [1–9] and the human microbiome [10–13].”
BackgroundResistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics
Bird, A., Conlon, M., Christophersen, C., & Topping, D. (2010) · Beneficial Microbes · doi:10.3920/bm2010.0041 · Cited by 195
“, 2006) and diabetes (Larsen et al., 2010; Petrovsky, 2010).”
Velázquez, K. T., Enos, R. T., Bader, J. E., Sougiannis, A. T., Carson, M. S., Chatzistamou, I., Carson, J. A., Nagarkatti, P., Nagarkatti, M., & Murphy, E. A. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i8.619 · Cited by 187
Metadata
- Authors
- Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M.
- Affiliations
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- Corresponding author
- Larsen, Nadja
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-05
- Volume
- 5
- Issue
- 2
- Pages
- e9085
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2816710
- OpenAlex
- W2135989088
- Cited by
- 2,952
- References
- 38
- Citations by year
- 2026: 90 · 2025: 168 · 2024: 217 · 2023: 199 · 2022: 296 · 2021: 331 · 2020: 294 · 2019: 264 · 2018: 191 · 2017: 158 · 2016: 174 · 2015: 150 · 2014: 134 · 2013: 115 · 2012: 83
- FWCI
- 36.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministeriet for Fø devarer, Landbrug og Fiskeri
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, gut microbiota, Firmicutes, Bacteroidetes, Betaproteobacteria, plasma glucose, glucose tolerance, obesity, metabolic disorders, 16S rRNA gene
- MeSH terms
- Adult, Aged, Bacteria, Diabetes Mellitus, Type 2, DNA, Bacterial, Feces, Humans, Intestines, Male, Middle Aged, RNA, Ribosomal, 16S, Colony Count, Microbial, Body Mass Index, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.